Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jesus Livio Jimenez Santos, Centro Universitario contra el Cáncer
ClinicalTrials.gov Identifier:
NCT02041351
First received: January 18, 2014
Last updated: January 26, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)